FDA rejects over the counter status for emergency contraceptive

BMJ 2004; 328 doi: 10.1136/bmj.328.7450.1219 (Published 20 May 2004)
Cite this as: BMJ 2004;328:1219.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Janice Hopkins Tanne
  1. New York

    Family planning groups, women's organisations, obstetricians and gynaecologists, legislators, and national newspapers in the United States protested last week at the Food and Drug Administration's refusal to permit sales over the counter (without a prescription) of an emergency contraceptive.

    In making his decision, Dr Steven Galson, acting director of the FDA's Center for Drug Evaluation and Research, overruled the organisation's own scientific advisory committee and its professional staff.

    Many experts said it was an attack on contraception by the anti-abortion Bush administration. But Dr Galson defended …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL